Analyst Ratings for Allscripts Healthcare Solutions Inc. (MDRX)

Updated: 2017-07-26

Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, MDRX was issued an average rating of Overweight.

9 analysts declared MDRX a buy, 2 gave an overweight rating, 14 issued a hold rating, 0 issued an underweight rating, and 1 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for MDRX. The most optimistic price target was 17, which equates to a potential upside of 35.89 percent. The most pessimistic analyst gave a price target of 11, which equates to a potential downside of -12.07 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes 0 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.26 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

In the trailing 52-weeks, MDRX hit 15.17 at the highest peak, while it's lowest trading point was 9.80. Currently the stock is 27.65 percent higher than its low, and below the high by 17.53 percent. MDRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDRX value stock report compares MDRX to some of its peers using value stock charts. The stock has a market capitalization of $2.25 billion. MDRX's next earnings release will be on 0000-00-00, which is days away.